Novel PSMA-targeting ligand PSMA-TO-1 shows prolonged circulation time and higher tumor uptake Oct. 25, 2021
Fusion Pharmaceuticals evaluates alpha particle-emitting NTSR1 antagonist for colorectal cancer Oct. 25, 2021
Shanghai Synergy Pharmaceutical Sciences, Zhejiang Huahai Pharmaceutical identify kinase inhibitors Oct. 25, 2021
Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent GLP-1 receptor agonists Oct. 25, 2021
RSS